Similarly, tumor cell-derived TGF-β signaling can trigger the release of several cytokines from CAFs, such as IL-6, CXCL10, and CCL5, which, in turn, drive the upregulation of glycogen metabolism in tumor cells through phosphoglucomutase 1 (PGM1) activation [115]. The gene discussed is CCL5; the disease is neoplasm.